SERIAL EVALUATION OF SERUM PROTEIN PROFILE FOLLOWING BREAST CANCER TREATMENT

乳腺癌治疗后血清蛋白谱的系列评估

• 批准号: 7605798
• 负责人: DAVID N KRAG
• 金额: $ 2.29万
• 依托单位: UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-03-01 至 2008-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7605798
• 关键词: Blood; Blood Proteins; Blood specimen; Breast Cancer Treatment; Cancer Patient; Clinical Research; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Diagnostic Neoplasm Staging; Effectiveness; Evaluation; Funding; Future; Goals; Grant; Individual; Institution; Operative Surgical Procedures; Patients; Prevalence; Process; Proteins; Protocols documentation; Research; Research Personnel; Resources; Serum Proteins; Source; Surgeon; Testing; Time; United States National Institutes of Health; Week; cancer type; malignant breast neoplasm; milliliter

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Recent studies on proteins in blood have demonstrated subtle changes in the protein profile between individuals that do have and individuals that do not have breast cancer. The primary goal of this clinical trial is to determine whether blood proteins are altered in patients with breast cancer and how long it takes for the alteration to normalize following surgical treatment of breast cancer. In the future, this may be a very important test to determine the staging of cancer and the effectiveness of breast cancer treatment. In this clinical study, the surgeon or a blood drawing technician will remove a sample of blood. A total of about 10 to 15 milliliters of blood will be removed and processed specifically per protocol. This will occur before surgery and additionally after surgery at 2 weeks, 4 weeks, and monthly for 6 months after surgery (8 draws in total). The goal of this trial is to determine the presence of changes in the protein profile in blood. The objectives of this trial are: Determine the prevalence of breast cancer type serum protein profile in breast cancer patients prior to surgery. Determine the time course of normalization of serum protein profile from cancer-type to normal-type.

这个子项目是众多研究子项目之一